Covid breakthrough as chewing gum found to ‘significantly weaken’ virus potential

Sturgeon grilled over strict Covid rules as Scotland rate exposed

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

A study has found that chitosan, which is a type of sugar derived from shellfish and mushrooms, can interfere with the virus’ ability to grab onto healthy cells and cause infection. Renowned immunologist Dr Karl Skriner, who created GoBeDo Immune Boosting Peppermint Gum, claims that his new gum could be particularly beneficial to those who work closely with other people – particularly medical practitioners who are often in the same room as those who test positive for Covid.”

Dr Karl Skriner commented: “Because of COVID-19’s high infection rate, the development of methods and tools to curb the spread of the virus have been the focus of the medical and scientific community.

“One compound of particular interest at the moment is Chitosan.

“The idea behind GoBeDo chewing gum is to put a long-lasting layer of Chitosan in our mouths, which also happens to be where the virus is likely to enter.

“When Covid-19 travels through our mouths, it’s met with Chitosan particles, which could significantly weaken the virus’s potential to infect the body.

An in vitro lab study testing the effectiveness of the gum found that it could provide an effective method of protection from Covid-19 plus other well-known viruses and bacteria.

Based on new research, GoBeDo Immune Boosting Gum secreted an average load of 1.8 mg per 15 minutes of chewing time.

Previous studies suggest at least 1 mg of Chitosan can produce protective effects from COVID-19.

Based on saliva samples, the study found that Chitosan from GoBeDo is still heavily present beyond 30 minutes after the first chew.

It was found that Chitosan strongly interacts both with the surface of the Covid-19 virus (Receptor Binding Domain) as well as with the binding site on the ACE2 receptor on the mucosa cell surface.

As a consequence, the infection is blocked both on the virus site and the mucosa site (double blocking principle).

In addition, the binding of Chitosan to the virus spike protein initiates a change on the virus surface that allows weak-binding antibodies to turn into strong-binding antibodies.

This means that even the low efficacy of weak antibodies can be strongly improved by the presence of Chitosan.

DON’T MISS 
Archaeologists baffled by skeleton that had been ‘rolled into a ditch’ [REPORT] 
Tourist spots under threat as mega iceberg leaks 152 tonnes of water [REVEAL] 
End of the world warning as evidence found for sixth mass extinction [INSIGHT] 

Chitosan has been shown to prevent Covid-19 from binding with a protein receptor called ACE-2, which regulates blood pressure and inflammation.

ACE-2 also functions to protect our lungs, specifically our alveoli, which aids breathing.

Dr Karl added: “Chitosan supplementation is nothing new, and several studies have shown that the human body can tolerate high amounts of Chitosan with no side effects.

“Armed with what we knew, the question then was; how do we supplement it in a way that would have it meet the virus the moment it enters?

“We answered our own question by putting it in our GoBeDo Immune Boosting Gum.”

Public health advice states that face masks and vaccinations

Source: Read Full Article